| If you use human derived material for R&D, you are certainly aware of the Biobank legislation (i.e.the law of 19 December 2008 on the acquisition and use of human body material for the purpose of human medical applications or scientific research, the RD of 9 January 2018 on biobanks). In the recently published law of 23 February a ‘lighter’ regime is elaborated for artificial material such as established cell lines and extracted material such as organelles, ribosomes, mitochondria, RNA and DNA. Artificial and extracted material do not any longer need to be registered and stored at an officially recognized biobank. However, the starting material (e.g. human tissue, human cells) used to extract material or to produce artificial material still needs to be registered and stored in an officially recognized biobank. This lighter regime is not applicable when performing genetic research on artificial or extracted material.
See: https://www.vbb.com/media/Insights_News/Wet_van_23_februari_2022.pdf for more detail. | |